All In Biotech

Drug Trial Radar · NCT06653738

Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention

Randomized Placebo-controlled Trial to Assess Efficacies of EMPAgliflozin and Personalized Dietary Counselling for Kidney STONE Prevention in Patients With Calcium Kidney Stones Acronym: EMPASTONE Trial

Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Jul 2, 2026

Primary completion

Sep 2030

Study completion Sep 2030

Sponsor

Lead sponsor
Insel Gruppe AG, University Hospital BernAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this randomized trial with a 2-by-2 factorial design is to test the efficacy of the SGLT2 inhibitor empagliflozin and personalized dietary counseling based on 24-hr urine collection results and dietary assessments for kidney stone recurrence prevention in patients with calcium kidney stones. Study interventions: * Empagliflozin 10 mg once daily per os for 36 months * Personalized dietary counseling for 36 months. Control interventions: * Placebo once daily per os for 36 months * Generic dietary counseling for 36 months.

Conditions

  • Kidney Stone
  • Nephrolithiasis
  • Dietary Exposure

Interventions

  • Empagliflozin 10 MGDrug

    Once daily per os for 3 years

  • PlaceboDrug

    Once daily per os for 3 years

  • Personalized dietary counselingBehavioral

    Personalized dietary counseling based on repeat 24-hr urine collections and dietary assessments for 3 years

  • Generic dietary counselingBehavioral

    Generic dietary counseling based on current guidelines without 24-hr urine collection results and without specific dietary assessments for 3 years

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of patients with radiologic stone recurrenceTime frame: After 3 years

Locations

21 sites in 4 countries. Site status is shown where the registry gives one.

  • University Hospital Amiens-Picardie

    Amiens, France · Not yet recruiting

  • Hôpital Tenon

    Paris, France · Not yet recruiting

  • Hôpital Européen Georges Pompidou

    Paris, France · Not yet recruiting

  • Charité University Medicine Berlin

    Berlin, Germany · Not yet recruiting

  • Università della Campania "Luigi Vanvitelli"

    Naples, Italy · Not yet recruiting

  • Verona University Hospital

    Verona, Italy · Not yet recruiting

  • Kantonsspital Aarau

    Aarau, Switzerland · Recruiting

  • Kantonsspital Baden

    Baden, Switzerland · Recruiting

  • University Hospital Basel

    Basel, Switzerland · Recruiting

  • Inselspital Bern

    Bern, Switzerland · Recruiting

  • Kantonsspital Chur

    Chur, Switzerland · Recruiting

  • Kantonsspital Fribourg

    Fribourg, Switzerland · Not yet recruiting

  • University Hospital Geneva (HUG)

    Geneva, Switzerland · Recruiting

  • Lausanne University Hospital (CHUV)

    Lausanne, Switzerland · Recruiting

  • Kantonsspital Luzern

    Lucerne, Switzerland · Not yet recruiting

  • Regionalspital Lugano

    Lugano, Switzerland · Not yet recruiting

  • Kantonsspital Neuchâtel

    Neuchâtel, Switzerland · Not yet recruiting

  • Kantonsspital Olten

    Olten, Switzerland · Not yet recruiting

  • Kantonsspital St. Gallen

    Sankt Gallen, Switzerland · Recruiting

  • Kantonsspital Sion

    Sion, Switzerland · Not yet recruiting

  • Universitätsspital Zürich

    Zurich, Switzerland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.